The main strategy to prevent transfusion-associated Chagas' disease is the identification of T. cruzi-infected blood donors by serological screening tests, however there is no perfect serological gold standard. We evaluated an enzyme immunoassay ( 
The current methods for detecting chronic T. cruzi infection are mainly based on identification of serum antibodies to the parasite [1] however, the serological diagnosis of infection is complex, falsely yielding both positive and negative results [2] [3] [4] . One additional problem that these assays must overcome is a potential cross-reactivity with other related protozoan diseases, particularly leishmaniasis [5] . For situations such as this, where there is no perfect serological gold standard, latent class analysis may be used to evaluate the sensitivity and specificity of diagnostic tests [6] . This method assumes that the true disease state is not directly unobservable, but that the available methods of observation approximate the true state in some way [7, 8] . We evaluated the performance of three commercially available serologic tests for detecting antibodies to T. cruzi among Brazilian blood donors. The serological results detected by enzyme immunoassay (EIA), indirect hemaglutination (IHA), and indirect immunofluorescence (IIF) methods were submitted to latent class model analysis. In addition, samples that gave repeatedly positive results by the serological screening tests were analyzed with a supplementary radioimmunopreciptation (RIPA) technique [9, 10] .
Materials and Methods
Study population. The blood donor population consisted of 1951 subjects who donated blood in São Paulo City, a non-endemic area for Chagas' disease in Brazil. Since most of the donors originated from different regions of Brazil, they were selected by a pre-donation questionnaire that included questions regarding their epidemiological risk of T. cruzi infection. Donors were asked: (1) Do you know the insect that transmits Chagas' disease?; and/or (2) Have you ever lived in a house with contaminated with this insect?
Laboratory tests. All sera were screened by three commercially available tests, including: (1) second generation EIA that used purified antigens derived from epimastigote and amastigote forms of Y and CL T. cruzi strains (Abbott Laboratories, Abbott Park, IL) [11] ; (2) IHA that employed antigens from epimastigote and amastigote forms of Y and CL T. cruzi strains at a 1-in-40 serum dilution (Biolab Diagnóstica, RJ, Brazil) [12] ; and (3) IIF that was done using antigens from epimastigote forms of T. cruzi in a 1-to-20 serum dilution (Biolab Diagnóstica, RJ, Brazil) [13] . Results were considered positive or negative by the EIA according to the cut-off value obtained by the mean value of the optical density (OD) from the negative controls plus 0.360, and then multiplied by the mean value of OD from the positive controls. An EIA result was considered negative at an OD identical to or higher than 0.020 but lower than the cut-off value, while an EIA result was considered initially reactive at an OD higher or identical to the cut-off value. The initially reactive samples were reevaluated in duplicate and if one of them was reactive, the sample was considered repeatedly reactive. If both duplicate tests were negative, the sample was considered negative for the presence of T. cruzi-antibodies.
For the IHA, results were considered negative when a pellet of red cells was formed at the bottom of the microplate well; results were considered positive when a uniform veil of red cells was formed covering all of the microplate well. A cloudy layer of red cells at the bottom of the microplate well was considered weakly positive or indeterminate. All initially positive or indeterminate samples were reevaluated in duplicate and if one of the duplicate tests was positive the sample was considered repeatedly positive.
A continuous emission of green fluorescence on the membrane of the T. cruzi in the IIF test was scored as a positive result while tests with an absent or a discontinuous (non-specific) pattern of green fluorescence emission on this membrane were considered negative. An IIF result was considered positive at a dilution titer of ≥ 20, and IHA at a dilution titer of ≥ 40.
To properly evaluate the sensitivity of the serological tests we examined 35 samples from persons with chronic T. cruzi infection confirmed by a xenodiagnosis test. The supplementary RIPA test was performed using a lysate prepared from extracted membrane proteins of T. cruzi.
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I labeled proteins were incubated with each sample and then immunoprecipitated using Protein A Sepharose. The eluted proteins were electrophoresed using acrylamide gels and imaged using autoradiography film. Samples with antibodies to T. cruzi showed reactivity to p32 and p34, and a band at p90 gave additional supporting data [9, 10] .
Statistical analysis. The latent class model allows for false-positive and false-negative errors to occur at certain rates in the test data; the test sensitivity is 1 -FNR (false negative rate) and the test specificity is 1 -FPR (false positive rate). For example, a positive test result is interpreted in the model as having come from either a true case of disease (thus, a correct result) or from a non-case (thus, an incorrect, false positive error). The mixing of these two possibilities occurs at unknown proportions, defined by the true disease prevalence [6] .
Using data from a set of individuals with several test results each, the model can estimate the error rates (or, equivalency, sensitivity and specificity) for each test and the disease prevalence. Observational errors are assumed to be conditionally independent (i.e. given the true disease state of an individual) between tests. A minimum of three tests is required to fit the model without making further assumptions about the parameter values. Parameter estimation is achieved by standard maximum likelihood methods, which also yield standard errors for the parameters [6] [7] [8] . Table 1) .
Results
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The results of the RIPA investigation are summarized in Table 2 . The RIPA test was found to be positive in 6 (85.7%) of 7, 4 (66.7%) of 6 and 7 (58.3%) of 12 tested samples that reacted exclusively with the EIA, IHA and IIF tests, respectively. In addition, we found that the RIPA test was positive in 4 (80%) of 5 samples that reacted simultaneously with the EIA, IHA and IIF tests, and in 2 (100%) samples that were positive by EIA and IIF. Table 3 shows the parameters estimated from the data incorporating EIA, IHA and IIF. All three tests appear to have excellent specificity values; the sensitivity was excellent for EIA and IIF, but IHA had a false negative rate of approximately 40 percent. Accordingly, the predictive values associated with almost all combinations of tests results were very close to 0 or 1 ( Table 4) .
The serological investigation of 35 known positive samples confirmed by a xenodiagnosis test showed a sensitivity rate of 100, 100 and 88.2% for EIA, IIF, and IHA, respectively. The RIPA test was found to be positive in 29/31 (93%), 29/31 (93%), and 24/26 (92%) positive samples confirmed by xenodiagnosis, and that were reactive by EIA, IIF, or IHA, respectively.
Discussion
The main strategies to prevent transfusion-associated Chagas' disease include the identification of putative infectious blood donors by risk history and by serological screening tests [1] . Since specific IgG levels rise soon after infection and titers of these antibodies remain high for life, the identification of T. cruzi-infected blood donors by serological tests has become the most accepted prophylactic alternative [14, 15] . Typically, the sensitivity and specificity rates of the serological tests, which are available to detect antibodies to T. cruzi, are very high when sera from patients with infection confirmed by xenodiagnosis or from persons who are not exposed to T. cruzi infection are tested. However, there are many discrepancies among techniques when they are carried out to identify putative infectious blood donors [16] .
We used 1951 sera obtained from Brazilian blood donors, without risk history for T. cruzi infection, for evaluating three serological assays routinely used for the detection of IgG antibodies against T. cruzi. When the results of three tests were submitted to a latent class model, we found not only a high sensitivity rate (100%) for the EIA and IIF techniques, but also a high specificity rate of 99.95% and 99.69% for the EIA and IIF, respectively. Although, the estimated sensitivity rate for IHA was quite low (60.02%), this test showed a high specificity rate (100%). The probability of being case according to latent class model analysis was 99.92% when both EIA and IIF tests were positive, and 100% for the association of the EIA, IIF, and IHA techniques.
Based on the estimated 100% sensitivity of EIA and IIF, if these tests are used in isolation there is still a possibility for a false positive result, since their estimated specificity is less than 100% (Table 3) . However, based on the latent class model results, in all instances where one of the two tests (EIA or IIF) was positive and the other one negative, it was always considered a false positive result (negative predictive value, NPV) [ Table  3 ]. In contrast, when both EIA and IIF are positive there is 99.92% confidence that the result comes from a true positive case (positive predictive value, PPV) [ Table 3 ]. This very high PPV can be further increased to 100% if the IHA test is also positive ( Table 3) . The RIPA has been used to screen sera for anti-T. cruzi IgG antibodies and to classify a sample as confirmed seroreactive, indeterminate, or nonreactive. Recently, a combination of two confirmatory assays, ELISA and RIPA, has been reported to result in a sensitivity and specificity approaching 100% [9, 10] . The results observed with RIPA in our study are more or less in accordance with what was demonstrated by the latent class model, suggesting that when both EIA and IIF are positive, the confidence that the result comes from a true positive case (PPV) is near 100% (Table 4) . However, RIPA is a very time-consuming technique, the number of samples that can be analyzed at a time is quite limited, and a more suitable technique is still needed to confirm positive results found with the serological screening assays routinely used in blood banks to detect antibodies to T. cruzi.
Probability of EIA-
Some countries have required that two tests be performed for blood bank screening of Chagas' disease because substantial uncertainty surrounds the sensitivity and specificity of the serological tests for T. cruzi infection in blood donors, and no good gold standard exists for unequivocally identifying infected subjects. We explored the latent class analysis modeling technique to circumvent this problem. According to our results in this study, using latent class analysis, the strategy of using two different serological techniques seems to optimize test results as one can considerably increase the PPV of being case going from one to two tests. In contrast, not much is gained by adding a third test if the first two tests are EIA and IFF (Table 4 ). In conclusion, in the absence of a universally accepted gold standard to confirm positive test results for detecting T. cruzi-infected blood donors, by using the latent class model, the most appropriate strategy seems to be the association of EIA and IIF.
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